1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with erythromycin in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (erythromycin) | Trials (erythromycin) | Recent Studies (post-2010) (erythromycin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 14,524 | 1,138 | 1,926 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | erythromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 1.156 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.045 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 1.156 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 1.156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, R; Feldman, C; Theron, AJ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and erythromycin
Article | Year |
---|---|
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.
Topics: Adult; Anti-Asthmatic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Azithromycin; Calcimycin; Cell Membrane; Clarithromycin; Erythromycin; Humans; Ionophores; Luminescent Measurements; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Respiratory Burst; Roxithromycin; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1996 |